Cambridge UK medical imaging technology pioneer, Objective Imaging Limited, has started production of a revolutionary new tissue scanner – the Glissando - thanks to funding from The Royal Bank of Scotland (RBS).
Vapourtec in Suffolk has developed the UV-150, a pioneering photochemical reactor that will lead to more efficient, precise, consistent, safe and scalable photochemical synthesis.
Cambridge medical technology that offers online psychological therapy is gaining further penetration throughout the NHS in the UK.
World-leading medical technology business Abcam is set to invest multi-millions in a new global growth programme that will see a significant extension of its product range and expansion into new international territories from its Cambridge platform.
Bug-busting specialist Tristel, which operates from the Cambridge UK technology cluster, is engaging with the FDA in a bid to have its infection control products adopted in the lucrative US market.
The fortunes of Cambridge’s first plant-based biotech, Phytopharm, have been transformed by last October’s acquisition of IXICO Ltd – a medical technology and diagnostics business – and created a commercial animal with growing global traction.
Cambridge UK medical technology business Discuva has joined forces with Swiss pharma giant Roche to combat life-threatening infections caused by multi-drug resistant bacteria.
CEO Dr Stuart Hendry has quit as a director of loss-making Cambridge UK medical technology business Sphere Medical Holding plc – a company he founded 12 years ago – and a new chief executive has been appointed to globally commercialise the lead device.
Horizon Discovery, the Cambridge UK medical technology innovator, is raising a minimum £25 million on a London float that will trigger global acquisitions, territorial expansion and an acceleration of products and services to target more patients with individual medicines based on their genetic makeup.
eg technology in Cambridge is part of an EU-backed consortium aiming to revolutionise melanoma treatment.
Leading players in a consortium pioneering a new generation of fibre-based diagnostic sensor are delivering an update on progress at a summit in the Cambridge UK technology cluster on February 27.
That old CAT magic has a new generation of antibody technology customers in its spell. A Cambridge startup inspired by John McCafferty, co-founder of Cambridge Antibody Technology, is creating new medical opportunities with its IP.
Pharma giant AstraZeneca has entered into a collaboration with the Cancer Research UK (CRUK) Cambridge Institute to temporarily locate up to 60 AZ scientists in the Institute.
Cambridge UK medical technology business Vectura Group plc has reaped €4.5 million (£3.6m) through fresh milestone payments in Germany, Romania and Belgium.
Cambridge based personalised medicines business Horizon Discovery has ventured out of house for the first time to strengthen its cell line arsenal.
Technology innovator Cambridge Design Partnership has created a breakthrough nappy disposal system for Mayborn Group – owner of the Tommee Tippee® brand of baby and toddler products in the UK.
- Horizon boosts gene editing armoury
- Cambridge invention to cut medical device errors
- $101m Nasdaq windfall boosts child epilepsy venture
- IVF pioneer raises war chest for acquisitions
- Cambridge heads $200k Africa glaucoma campaign
- FDA backs Consort Medical autoinjector
- Cambridge medtech matches US, says AstraZeneca
- Jackpot in Japan shows yen for Horizon cell technology
- letscellit.com launches Cambridge BioPharma Cluster Map
- What Hollywood imagines, Tsui turns into reality
- Sareum granted US cancer drug patent
- 10p medtech sensor could lead to smartphone test
- Abcam opens China operation
- Cambridge University makes millions from BlueGnome sale
- TTP and Atlas unveil fast infectious disease diagnostic
- F1 technology fast-tracks obesity research
Page 1 of 54